Funding Details
- Date Award
- May 13, 2024
- Vertical
- Sustainable Manufacturing
- Funding URL
- View Funding Page
Company Info
- Traction
- None
- Organizations Involved
- None
- Founders
- None
- Company Description
- BryoSphere Biotechnologies uses moss plants and biotechnology techniques to synthesize rare, plant-derived specialty compounds. By harnessing the genetic information of a variety of plants, BryoSphere achieves the production of rare compounds with significantly higher yields compared to those found in their natural counterparts, thereby enhancing accessibility. Currently, BryoSphere is dedicated to the development of two key products: one for addressing skin hyperpigmentation in topical treatments, and another as an anti-cancer drug.
- Market
- Therapeutics
- Location
-
Canada
- Coinvestors
- None
Links